Retlirafusp alfabintrafusp alfaSHR-1701chemotherapyPD-L1-positive advanced gastric or gastroesophageal junction adenocarcinoma
…Retlirafusp alfa (SHR-1701), a bifunctional programmed death-ligand 1 (PD-L1) an…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 2,461–2,520 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
Pramlintide1S0950291Sugemalimab117-HDHA1AC4841AK1351ASP98011AVA-NP-6951AbLecs1Afami-cel1BA-H1C921CHS-1141CLEC2A1CRB-6011Cortrak21DAB+TRAM1F9H41FNET1FTD-TPI1Ferric maltol1Frataxin1GEN30091Glucosamine1HIVST1IL-2cx1JL180081Lete-cel1NButGT1PAL1PFCL1PLT0121Pabrinex1SKIV2L1SOTA1SUSD21Sch A1Sedation1SuHx1TJ-CP3B1WAY-1021WBMP-41ZM0081sdLDL-C1αVEGF14-OI1A2B6941ABC/21ABT-8631ARN-32361ASCENT1AZD67501Ambroxol1BJIKT1Brensocatib1CAN-24091CLM-0221CM9LA1CT1111DMED1
Articles mentioning drugs
10,506 articles · page 330 of 876calcium channel blockersangiotensin receptor blockersARBsCCBsHypertensionchronic kidney diseaseend-stage renal diseasemyocardial infarctionCKDkidney failure+3 more
…dney disease. Although angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs) are widely used antihypertensive agents in CKD, comparat…
faecal calprotectinIBD-Control Questionnaireulcerative colitis
…tients (55% female; median age 53 years, IQR 41–62) with paired faecal calprotectin (FCP) and IBD-Control-8 data, FCP correlated moderately with IB…
ursodeoxycholic acidUDCAPrimary biliary cholangitisPBC
…imit of normal (ULN), and to identify predictors of response to ursodeoxycholic acid (UDCA).Methods We conducted a single-centre retrospective study…
Orodispersible budesonideEosinophilic oesophagitis (EoE)endoscopic dilatationproton pump inhibitorsEoEdietary eliminationswallowed topical corticosteroids
… in 10/60 (17%), 6/10 on 0.5mg BD and 4/10 on 1mg OD.Conclusion Orodispersible budesonide achieved high rates of histological remission following inducti…
PERTFE-1PERTDiabetes mellituspancreatic diseasePancreatic exocrine insufficiency
…e formally diagnosed with PEI, of whom 128/133 (96.2%) received PERT. Follow up data were available for 84/128 (65.6%). Of these, sy…
aCRN RATOxford University Hospitals NHS Trustcolonic IBDOUH NHS Trustmultifocal LGD
…urveillance interval. At Oxford University Hospitals NHS Trust, aCRN RAT has been incorporated into IBD surveillance assessment.Methods …
86.6%
JAK inhibitorIL-12/23anti-IL-12/23anti-TNFulcerative colitisrheumatoid arthritispolymyalgia rheumaticaileocolonic diseaseInflammatory bowel diseaseGRC+3 more
…s switches were anti-TNF to anti-IL-12/23 (n=5) and IL-12/23 to JAK inhibitor (n=4). Non-medication-related actions (e.g. investigations or r…
ustekinumabvedolizumabadalimumabinfliximabInflammatory Bowel Diseaseulcerative colitisCrohn’s diseasechronic diseaseBMC Health Services ResearchNHS+1 more
…uired minor adjustment. Templates of moderate duration included ustekinumab, vedolizumab, and adalimumab counselling, with completion times…
sucralfateproton pump inhibitorH2RAintramucosal adenocarcinomaBarrett’s esophagusBE-Dearly neoplasiaLGDCE-Dintestinal metaplasia+4 more
…ived high-dose proton pump inhibitor twice daily and 14 days of sucralfate (2 g, three times daily). Adjunct argon plasma coagulation (APC…
NSBBsBaveno VIIBristol Royal Infirmaryhepatocellular carcinomaportal hypertension
… count. 55 (30.2%) should have had non-selective beta blockers (NSBBs) initiated without an OGD, 4 (7.27%) of whom only received NSBB…
96.9%
propofolmidazolamfentanylanticoagulantsBuried bumper syndromeBBSNutrition team
… mg (0.5-3 mg) and 50 mcg (50-100 mcg) respectively, 3 required propofol. Bleeding occurred in 1 (9%) case which was treated endoscopica…